Opsoclonus-myoclonus-ataxia syndrome (often referred to as OMAS or opsoclonus-myoclonus syndrome) is an autoimmune disorder of the nervous system characterized by new movements of …

OMAS is a type of autoimmune disease that affects the brain, nerves and eyes. Learn about the causes, symptoms, diagnosis, treatment and outlook in children.

Oct 7, 2024 · Opsoclonus-myoclonus-ataxia syndrome (OMAS), also known as opsoclonus-myoclonus, is a rare and debilitating acquired nervous system disorder characterized by opsoclonus, diffuse or …

The OMAS mission is to assist the efficient and effective administration of Ohio’s Medicaid program. OMAS is a mail, web, and random digit dial telephone survey that began fielding in 1997.

Mar 8, 2022 · Background and objectives: Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare disorder of the nervous system that classically presents with a combination of characteristic eye …

Sep 1, 2024 · Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare neuroimmune disease with peak onset at 18 months, associated with neural crest tumors in 50% of patients. In part due to its …

OMAS often arises as a paraneoplastic phenomenon in children who present with neuroblastomas and related tumors.

Oct 25, 2023 · Learn about Opsoclonus-Myoclonus-Ataxia Syndrome, including symptoms, causes, and treatments. If you or a loved one is affected by this condition, visit NORD.

Discover the timeless elegance of OMAS pens—handcrafted in Italy since 1925. From the iconic Arte Italiana to exclusive limited editions, OMAS delivers Italian artistry and writing excellence.

Mar 31, 2014 · Described in 1962, the opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare, neurologically debilitating disorder with distinct characteristics that may begin in childhood or adult …